Impact of salvage treatment phase on inotuzumab ozogamicin treatment for relapsed/refractory acute lymphoblastic leukemia: an update from the INO-VATE final study database
暂无分享,去创建一个
H. Kantarjian | E. Jabbour | W. Stock | D. DeAngelo | S. O'brien | A. Advani | E. Vandendries | N. Gökbuget | R. Cassaday | D. Marks | M. Stelljes | Tao Wang | A. Neuhof